JICHI MEDICAL UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1975-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.jichi.ac.jp
Clinical Trials
110
Active:0
Completed:63
Trial Phases
4 Phases
Phase 1:5
Phase 2:4
Phase 4:8
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (107 trials with phase data)• Click on a phase to view related trials
Not Applicable
90 (84.1%)Phase 4
8 (7.5%)Phase 1
5 (4.7%)Phase 2
4 (3.7%)A Study to Define the Distribution of Type of Hypertension in Asia by Blood Pressure Monitoring at Home (Asia BP@Home)
Completed
- Conditions
- Hypertension
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 1462
- Registration Number
- NCT03096119
- Locations
- 🇯🇵
Jichi Medical University, Tochigi, Japan
SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)
Phase 4
Completed
- Conditions
- Nocturnal HypertensionT2DM (Type 2 Diabetes Mellitus)
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2018-03-27
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 174
- Registration Number
- NCT03050229
- Locations
- 🇯🇵
Fukuoka University Chikushi Hospital, Fukuoka, Japan
🇯🇵Kotake Hospital, Fukuoka, Japan
🇯🇵Onga Hospital, Fukuoka, Japan
To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 82
- Registration Number
- NCT02849184
- Locations
- 🇯🇵
Takahira Internal Medicine Clinic, Fukuoka, Japan
🇯🇵Yamasaki family clinic, Hyogo, Japan
🇯🇵Yagi hospital, Tokyo, Japan
AADC Gene Therapy for Parkinson's Disease
Phase 1
Terminated
- Conditions
- Parkinson Disease
- First Posted Date
- 2015-04-16
- Last Posted Date
- 2019-08-09
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 2
- Registration Number
- NCT02418598
- Locations
- 🇯🇵
Jichi Medical University, Shimotsuke, Tochigi, Japan
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes
Phase 1
- Conditions
- Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- Interventions
- Genetic: Dose Level 1Genetic: Dose Level 2Genetic: Dose Level 3Genetic: Dose Level -1
- First Posted Date
- 2014-05-09
- Last Posted Date
- 2014-11-06
- Lead Sponsor
- Jichi Medical University
- Target Recruit Count
- 18
- Registration Number
- NCT02134262
- Locations
- 🇯🇵
Jichi Medical University, Shimotsuke, Tochigi, Japan
- Prev
- 1
- 2
- Next
News
No news found